Status:
COMPLETED
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
Lead Sponsor:
Fundación GECP
Conditions:
Lung Cancer
COVID
Eligibility:
All Genders
18+ years
Brief Summary
Observational, retrospective data collection and prospective IgG analysis, and multicenter study. The main objective of the study is th description of the characteristics and evolution of patients wi...
Detailed Description
Non-post-authorization study, retrospective of data collection and prospective of IgG analysis, observational and multicenter. The study will be extended to all the sites of the Spanish Lung Cancer G...
Eligibility Criteria
Inclusion
- Patients diagnosed with lung cancer at any stage of the disease
- Age ≥ 18
- Patients who have signed the informed consent for this study
Exclusion
- 1\. Patients who have not signed or do not wish to sign the informed consent for this study
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
1980 Patients enrolled
Trial Details
Trial ID
NCT04407143
Start Date
April 15 2020
End Date
May 30 2022
Last Update
June 3 2022
Active Locations (68)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Elche
Elche, Alicante, Spain, 03203
2
ICO Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain, 08908
3
Hospital Universitario Insular de Gran canaria
Las Palmas de Gran Canaria, Gran Canaria, Spain, 35016
4
Hospital Universitario de Torrejón
Torrejón, Madrid, Spain